Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Lucantoni

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cell Death & Disease|April 21, 2022
Implication of autophagy in the antifibrogenic effect of Rilpivirine: when more is lessFederico Lucantoni, Ana M Benedicto, Aleksandra Gruevska, et al.
The Journal of Pathology|April 9, 2021
Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?Federico Lucantoni, Andreu Martínez-Cerezuela, Aleksandra Gruevska, et al.
ACS Chemical Biology|June 7, 2014
Peptides derived from the transmembrane domain of Bcl-2 proteins as potential mitochondrial priming toolsVicente Andreu-Fernández, Ainhoa Genoves, Tzong-Hsien Lee, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 3, 2018
Low cleaved caspase-7 levels indicate unfavourable outcome across all breast cancersAndreas U Lindner, Federico Lucantoni, Damir Varešlija, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 30, 2024
Interference with mitochondrial function as part of the antifibrogenic effect of Rilpivirine: A step towards novel targets in hepatic stellate cell activationAna M Benedicto, Federico Lucantoni, Isabel Fuster-Martínez, et al.
Cell Death and Differentiation|June 30, 2026
Cell engulfment defines spatially distinct competitive metabolic niches associated with clinical outcomes in colorectal cancerEmir Bozkurt, Batuhan Kisakol, Heiko Dussmann, et al.
Cancers|October 17, 2020
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft ModelsAlice C O'Farrell, Monika A Jarzabek, Andreas U Lindner, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cell Death & Disease|April 21, 2022
Implication of autophagy in the antifibrogenic effect of Rilpivirine: when more is lessFederico Lucantoni, Ana M Benedicto, Aleksandra Gruevska, et al.
The Journal of Pathology|April 9, 2021
Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?Federico Lucantoni, Andreu Martínez-Cerezuela, Aleksandra Gruevska, et al.
ACS Chemical Biology|June 7, 2014
Peptides derived from the transmembrane domain of Bcl-2 proteins as potential mitochondrial priming toolsVicente Andreu-Fernández, Ainhoa Genoves, Tzong-Hsien Lee, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 3, 2018
Low cleaved caspase-7 levels indicate unfavourable outcome across all breast cancersAndreas U Lindner, Federico Lucantoni, Damir Varešlija, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 30, 2024
Interference with mitochondrial function as part of the antifibrogenic effect of Rilpivirine: A step towards novel targets in hepatic stellate cell activationAna M Benedicto, Federico Lucantoni, Isabel Fuster-Martínez, et al.
Cell Death and Differentiation|June 30, 2026
Cell engulfment defines spatially distinct competitive metabolic niches associated with clinical outcomes in colorectal cancerEmir Bozkurt, Batuhan Kisakol, Heiko Dussmann, et al.
Cancers|October 17, 2020
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft ModelsAlice C O'Farrell, Monika A Jarzabek, Andreas U Lindner, et al.
Pageof 2